# Arbutus Biopharma Corp: Form DEF 14A, filed Dec 6, 2017

- Company: [Arbutus Biopharma Corp](/companies/abus.md) (CIK 1447028)
- Form: DEF 14A
- Filed: 2017-12-06
- Accepted by EDGAR: Dec 6, 2017, 14:54 ET
- Period: 2017-12-06
- Accession: 0001628280-17-012143
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1447028/000162828017012143/specialmeetingproxydefinit.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1447028/000162828017012143/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1447028/000162828017012143/specialmeetingproxydefinit.htm

Filed Dec 6, 2017.
Source: SEC EDGAR, the filing index for accession 0001628280-17-012143. Last ingested by Listed: Nov 12, 2026, 17:55 ET. No prices; not investment advice.